title: [Insulin treatment in diabetes mellitus type II: the usefulness of the breakfast test].
abstract: BACKGROUND
  Insulin treatment in patients with type-II diabetes mellitus (DMII) is normally undertaken by clinical criteria. The aim of the present was to study the efficacy of a standard mixed meal (breakfast test) to predict the need for insulin therapy to thereby evaluate whether it is possible to obtain more objective criteria for the indication of insulin treatment.
  
  
  METHODS
  Fifty-six patients with DMII were studied to evaluate the need for insulin therapy over a one-year period. Serum glucose and basal C peptide and their maximum values were determined in all the patients following stimulation with the breakfast test. Insulin treatment was initiated according to exclusively clinical criteria during admission. The patients were followed as out patients for a minimum of 3 months. Treatment at the end of follow up (insulin or no insulin) was evaluated and the results of the test were retrospectively analyzed.
  
  
  RESULTS
  The basal C peptide (BCP) values were significantly lower in the individuals requiring insulin in comparison to those who did not require insulin (mean +/- SD 0.64 +/- 0.28 versus 1.18 +/- 0.41 nmol/l, p < 0.0001) similar to what was found with the stimulated maximum C peptide values (MCP) (1.48 +/- 0.77 versus 2.49 +/- 0.63 nmol/l, p < 0.0001). On considering a BCP of less than 0.9 nmol/l for the patients with insulin treatment the sensitivity of BCP was 83.6% and the specificity 78.9%. For a BCP value of less than 1.9 nmol/l sensitivity was 77.7% and specificity 78.9%. Using the values together, sensitivity was 66.6% and specificity 84.4%.
  
  
  CONCLUSIONS
  The breakfast test is useful to indicate the need for insulin therapy in patients with type II diabetes mellitus but is not more useful than a determination of isolated basal C peptide.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Clínic i Provincial, Barcelona.
authors.forename: J M
authors.initials: JM
authors.lastname: Manzanares
authors.forename: I
authors.initials: I
authors.lastname: Conget
authors.forename: J M
authors.initials: JM
authors.lastname: González-Clemente
authors.forename: J
authors.initials: J
authors.lastname: Vidal
authors.forename: C
authors.initials: C
authors.lastname: Rodríguez-Villar
authors.forename: I
authors.initials: I
authors.lastname: Rojas
authors.forename: F
authors.initials: F
authors.lastname: Fernández-Fernández
authors.forename: R
authors.initials: R
authors.lastname: Casamitjana
authors.forename: R
authors.initials: R
authors.lastname: Gomis
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose / Q000032:analysis; D016009:Chi-Square Distribution; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D004435:Eating / Q000502:physiology*; D005215:Fasting / Q000097:blood; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007328:Insulin / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood; D012680:Sensitivity and Specificity; D013997:Time Factors
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin; D010455:Peptides; C050632:polypeptide C
vernacular_title: Insulinización en la diabetes tipo II: utilidad de la prueba del desayuno.